Cargando…

Role of prostaglandins in tumour necrosis factor induced weight loss.

Administration of either tumour necrosis factor alpha (TNF-alpha) or 16,16-dimethylprostaglandin E2 (PGE2) to female NMRI mice caused a decrease in body weight accompanied by a reduction in both food and water intake and a decrease in carcass water content. A single injection of TNF-alpha caused an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahony, S. M., Tisdale, M. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247348/ https://www.ncbi.nlm.nih.gov/pubmed/2803915

Ejemplares similares

Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
por: Mahony, S. M., et al.
Publicado: (1988)

Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.
por: Mahony, S. M., et al.
Publicado: (1988)

Metabolic effects of tumour necrosis factor alpha in NMRI mice.
por: Mahony, S. M., et al.
Publicado: (1990)

Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.
por: Beck, S. A., et al.
Publicado: (1990)

Effect of insulin on weight loss and tumour growth in a cachexia model.
por: Beck, S. A., et al.
Publicado: (1989)

Reduction of weight loss and tumour size in a cachexia model by a high fat diet.
por: Tisdale, M. J., et al.
Publicado: (1987)

A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia model.
por: Tisdale, M. J., et al.
Publicado: (1988)

Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis
por: Neniskyte, Urte, et al.
Publicado: (2014)

Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.
por: Tisdale, M. J., et al.
Publicado: (1983)

Prostaglandins from tumours of human large bowel.
por: Bennett, A., et al.
Publicado: (1977)

Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage
por: Sanders, P M, et al.
Publicado: (2004)

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2014)

Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor
por: Russell, S T, et al.
Publicado: (2002)

Induction of muscle protein degradation by a tumour factor.
por: Lorite, M. J., et al.
Publicado: (1997)

Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor
por: Romano, M., et al.
Publicado: (1997)

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
por: Shah, P., et al.
Publicado: (1989)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Sphingosine synergistically stimulates tumor necrosis factor alpha- induced prostaglandin E2 production in human fibroblasts
Publicado: (1991)

The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids
por: Cecilio, C. A., et al.
Publicado: (1997)

Prostaglandin F2 alpha in benign and malignant breast tumours.
por: Vergote, I. B., et al.
Publicado: (1985)

Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in rats.
por: van der Zee, J., et al.
Publicado: (1995)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
por: Tse, Brian W. C., et al.
Publicado: (2012)

A nontoxic tumour necrosis factor induced by streptococcal lipoteichoic acids.
por: Usami, H., et al.
Publicado: (1987)

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
por: Kim, Eugene Y, et al.
Publicado: (2008)

Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss
por: Cabal-Manzano, R, et al.
Publicado: (2001)

Colonial morphology of tumour cells and susceptibility to cytolysis by tumour necrosis factor. The role of cellular fibronectin deposition in the extracellular matrix.
por: Neale, M. L., et al.
Publicado: (1990)

Metabolic substrate utilization by a tumour cell line which induces cachexia in vivo.
por: Tisdale, M. J., et al.
Publicado: (1986)

Carnitine and congeners as regulators of tumour necrosis factor
por: De Simone, Claudio, et al.
Publicado: (1993)

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
por: MÃ¤nnel, D. N., et al.
Publicado: (1989)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

The Role of Costimulatory Receptors of the Tumour Necrosis Factor Receptor Family in Atherosclerosis
por: Antunes, Ricardo F., et al.
Publicado: (2012)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.
por: Groundwater, P., et al.
Publicado: (1990)

Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo
por: Russell, S T, et al.
Publicado: (2002)

Tumour necrosis factor in man: clinical and biological observations.
por: Selby, P., et al.
Publicado: (1987)

Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation
por: Islam-Ali, B S, et al.
Publicado: (2001)

Inhibition of tumour growth by lipoxygenase inhibitors.
por: Hussey, H. J., et al.
Publicado: (1996)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_orbdk4h85dcr10c57kds8pn2m0